RCT: Online Family Intervention Reduces Drug Initiation in Hispanic Youth (US Primary Care)

Online Family Intervention Reduces Drug Initiation in Hispanic Youth

A randomized clinical trial conducted across 15 US pediatric primary care clinics found that a culturally tailored, online family intervention significantly reduced drug and hard drug initiation—including substances such as lysergic acid diethylamide (LSD), 3,4-methylenedioxymethamphetamine (MDMA), and psilocybin mushrooms—among Hispanic adolescents. The trial, registered as NCT03009539, enrolled 456 adolescent-parent dyads and followed them for up to 36 months, with data collection spanning from April 2017 to December 2022. The intervention, eHealth Familias Unidas Primary Care (eHealth FUPC), consisted of eight online video group sessions for parents and four facilitator-guided family sessions, delivered over approximately 12 weeks by pediatric primary care staff.

Mechanism and Context: Family Engagement and Cultural Tailoring

The eHealth FUPC intervention leverages family engagement and cultural tailoring to address risk behaviors among Hispanic youth. The program's design reflects evidence that family functioning and parental involvement are critical protective factors against adolescent substance use, particularly in Hispanic communities where familial bonds and cultural identity play a central role. While the intervention improved drug use outcomes, it did not produce significant changes in condom use or overall family functioning, suggesting that reductions in drug initiation may be driven by targeted prevention messaging and increased parental monitoring rather than broad shifts in family dynamics.

An insight not widely discussed in prevention literature is the program's reliance on primary care personnel as interventionists, which may enhance trust and scalability but also introduces variability in fidelity and sustainability across different clinical settings. The study's high retention rate (78.1% at final assessment) underscores the feasibility of integrating such interventions into routine pediatric care, though long-term maintenance remains uncertain.

Policy and Research Implications for Substance Use Prevention

Evidence from this trial supports the integration of culturally tailored, digital family interventions into primary care as a scalable strategy for preventing adolescent drug use, including psychedelics. For policymakers and public health officials, these findings highlight the importance of upstream prevention efforts that address risk behaviors before clinical or legal interventions become necessary. The trial's focus on Hispanic youth addresses a population often underrepresented in substance use prevention research, offering a model that could be adapted for other communities with high risk or unique cultural needs.

For researchers, the study raises questions about the mechanisms by which such interventions reduce drug initiation—particularly whether effects are mediated by specific components (e.g., parental monitoring, cultural affirmation) or the broader context of family engagement. The lack of significant change in family functioning metrics suggests that targeted prevention content may be more influential than global improvements in family relationships. Future research should examine which elements drive efficacy and how digital delivery can be optimized for diverse populations.

Risks, Limitations, and Unknowns

While the eHealth FUPC program demonstrated efficacy in reducing drug initiation, several limitations and risks warrant consideration. The study did not address clinical use of psychedelics or differentiate between recreational and experimental use, limiting its direct applicability to debates about therapeutic access. The intervention's effects on other risk behaviors (such as condom use) were minimal, and family functioning did not significantly improve, indicating that benefits may be domain-specific.

Generalizability is constrained by the exclusive focus on Hispanic youth in US primary care settings and the high proportion of female caregivers. The COVID-19 pandemic interrupted data collection for sexually transmitted infections (STIs), which were relegated to secondary outcomes. Additionally, the sustainability of such interventions within busy clinical environments remains an open question, with potential barriers including staff training, reimbursement, and competing priorities.

Forward Look: Prevention, Equity, and Future Directions

This trial provides robust evidence that culturally tailored, online family interventions can reduce adolescent drug initiation—including for substances like LSD and psilocybin—when delivered in primary care. As public interest in psychedelics grows and regulatory landscapes shift, prevention strategies targeting youth remain essential for balanced policy. The study's approach—leveraging digital tools, cultural context, and family engagement—offers a template for future interventions aiming to address substance use risk in diverse populations.

Further research should explore adaptation for other communities, long-term sustainability in real-world clinics, and the specific mechanisms underlying observed effects. As digital health interventions proliferate, ensuring equity, fidelity, and cultural relevance will be critical to maximizing public health impact.

How we research: This article was written and reviewed by Dr. Ana M. Torres, PhD (public health researcher), on 2026-10-10. Primary sources: OpenAlex, ClinicalTrials.gov NCT03009539.